Dr. Olga Kozyreva, MD
Claim this profileDana-Farber Cancer Institute at St. Elizabeth's Medical Center
Studies Prostate Cancer
Studies Hematologic Malignancies
6 reported clinical trials
11 drugs studied
Area of expertise
1Prostate Cancer
BRCA1
BRCA2
NTRK1
2Hematologic Malignancies
Stage IV
Affiliated Hospitals
Clinical Trials Olga Kozyreva, MD is currently running
SURGE Support Program
for Cancer Trial Enrollment
This trial aims to help underrepresented cancer patients understand and agree to genomic testing by providing a guide, sending text message questions, and showing an informational video. The goal is to make it easier for these patients to access personalized treatments and clinical trials. By addressing their educational and social needs, the intervention supports better decision-making about their care.
Recruiting1 award N/A
Blood Test and Immunotherapy
for Bladder Cancer
This phase II/III trial examines whether patients who have undergone surgical removal of bladder, kidney, ureter or urethra, but require an additional treatment called immunotherapy to help prevent their urinary tract (urothelial) cancer from coming back, can be identified by a blood test. Many types of tumors tend to lose cells or release different types of cellular products including their DNA which is referred to as circulating tumor DNA (ctDNA) into the bloodstream before changes can be seen on scans. Health care providers can measure the level of ctDNA in blood or other bodily fluids to determine which patients are at higher risk for disease progression or relapse. In this study, a blood test is used to measure ctDNA and see if there is still cancer somewhere in the body after surgery and if giving a treatment will help eliminate the cancer. Immunotherapy with monoclonal antibodies, such as nivolumab and relatlimab, can help the body's immune system to attack the cancer, and can interfere with the ability of tumor cells to grow and spread. This trial may help doctors determine if ctDNA measurement in blood can better identify patients that need additional treatment, if treatment with nivolumab prolongs patients' life and whether the additional immunotherapy treatment with relatlimab extends time without disease progression or prolongs life of urothelial cancer patients who have undergone surgical removal of their bladder, kidney, ureter or urethra.
Recruiting1 award Phase 2 & 310 criteria
More about Olga Kozyreva, MD
Clinical Trial Related6 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Olga Kozyreva, MD has experience with
- Nivolumab
- SURGE
- Bevacizumab
- Cholecalciferol
- Fluorouracil
- Irinotecan
Breakdown of trials Olga Kozyreva, MD has run
Hematologic Malignancies
Gastrointestinal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Olga Kozyreva, MD specialize in?
Olga Kozyreva, MD focuses on Prostate Cancer and Hematologic Malignancies. In particular, much of their work with Prostate Cancer has involved BRCA1 patients, or patients who are BRCA2.
Is Olga Kozyreva, MD currently recruiting for clinical trials?
Yes, Olga Kozyreva, MD is currently recruiting for 3 clinical trials in Brighton Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Olga Kozyreva, MD has studied deeply?
Yes, Olga Kozyreva, MD has studied treatments such as Nivolumab, SURGE, Bevacizumab.
What is the best way to schedule an appointment with Olga Kozyreva, MD?
Apply for one of the trials that Olga Kozyreva, MD is conducting.
What is the office address of Olga Kozyreva, MD?
The office of Olga Kozyreva, MD is located at: Dana-Farber Cancer Institute at St. Elizabeth's Medical Center, Brighton, Massachusetts 02135 United States. This is the address for their practice at the Dana-Farber Cancer Institute at St. Elizabeth's Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.